UMass Chan VISTA Pathway in Digital Medicine Entrepreneurship, Biomedical Innovation and Design teaches digital medicine product development using the process of ideation, validation, and prototype creation. Medical students will learn the essential elements of the Business Model Canvas and Customer Discovery throughout this pathway. Longitudinal projects focus on digital medicine device development; creation of software tools to improve diagnosis, management, and monitoring of disease; and clinical assessments of market need for new medical products. Candidates must first apply and be accepted to the VISTA Pathway in Entrepreneurship, Biodesign and Innovation, then declare a digital medicine focus. Candidates interested in the digital medicine focus may email PDM@umassmed.edu for more information.

UMass Chan Medical Scientist Training Program Digital Medicine Pathway offers exceptional training opportunities for those interested in pursuing a career as a physician/scientist with a focus in digital medicine. Candidates must first apply and be accepted to the MD/PhD Medical Scientist Training Program, then may choose the digital medicine pathway. Candidates interested in the digital medicine pathway may email PDM@umassmed.edu for more information.

Self-guided opportunities for education, research, collaboration, and mentorship for medical students. Coming soon.

UMass Chan Fellowship in Digital Medicine builds expertise in the emerging field of digital medicine, promoting innovation through scholarship, research, and clinical training in digital medicine. Fellows will develop a research program designed to foster their area of interest while also gaining expertise across the multiple domains of digital medicine including machine learning, artificial intelligence, electronic health record (big data-based) research, virtual medicine, and mobile health (mHealth)​. Fellows will also learn innovation frameworks as they pertain to digital medicine including fundamentals of Biodesign, need-driven technology development, and human-centered design. Interested candidates may email PDM@umassmed.edu for more information. The 2023-2024 application cycle is now closed. The 2024-2025 application cycle opens April 14, 2023. Apply Here

Self-guided opportunities for education, research, collaboration, and mentorship for residents. Coming soon.

The Digital Acceleration of Smart Healthcare (DASH) Consortium is a partnership between UMass Chan Program in Digital Medicine, UMass Memorial Medical Center, and the UMass Lowell M2D2 IMPACT Accelerator that offers opportunities for UMass Memorial Medical Center physicians interested in the intersection of academia and industry, digital medicine innovation, and/or sponsored research to partner with the inventors of cutting-edge technology incubated within the UMass innovation ecosystem with intersecting or aligned interests.

Clinicians are strategically paired with a digital medicine venture based on affinity-matching or via direct request to pair with a particular company or inventor. Activities within the DASH Consortium are tailored to faculty member interests and desired level of engagement, and may include but are not limited to:

• serving as a principal or co-investigator for research in areas of interest
• learning about technology innovation and entrepreneurship through real-world participation
• participation in the biodesign process/human-centered design for novel technology
• co-development of intellectual property (e.g. patents, trademarks)
• joining an advisory board or serving as an advisor / subject matter expert

Application to the DASH Consortium is open to all physicians within UMass Memorial Medical Center. Interested faculty can email PDM@umassmed.edu for more information. Apply Here.

Self-guided opportunities for education, research, collaboration, and mentorship for attendings. Coming soon.

UMass M2D2 Impact Accelerator is a 12-week accelerator program that aims to advance early-stage companies looking to reshape the future of healthcare. Ventures in digital medicine partner with PDM for additional resources, subject matter expertise and guidance on approaching pilots and collection of early clinical data.

UMass Center for Advancing Point of Care Technologies supports development, deployment and testing of promising late-stage, point-of-care technologies that can be rapidly deployed to enhance the diagnosis, monitoring, management and treatment of heart, lung, blood, and sleep disorders. The center has an additional interest in projects that incorporate complementary and integrative health approaches. CAPCaT is supported by the National Heart, Lung and Blood Institute and the National Center for Complementary and Integrative Health. Ventures in digital medicine partner with PDM for additional resources, subject matter expertise and guidance on approaching pilots and collection of early clinical data, as well as access to the National Institutes of Health Point of Care Technology Research Network, Massachusetts Medical Device Development team, and more.